Pluri Inc.

Regulatory Filings • Feb 20, 2019

_________ false

�������� ��������� ����	2 381
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001	8544
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	20/02/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-016113	Time of broadcast: 14:22 14:04:49

---

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.

	Delay the publication of a report	_________	_________

1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Pluristem Enters into Collaboration with NASA to Study PLX Therapeutic Benefits in Space Missions

Pluristem_NASA_final_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 19/02/2019
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: Info@Pluristem.Com   Company site: www.pluristem.com
Previous names of reporting entity:
Name of the Signatory: Aberman Zalman Position of Signatory in the reporting corporation: Chairman Of The Board & CEO Name of Employer Company:
Address: Matam Park 20 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7107172 E-mail: zami@pluristem.com 2